alzheimer's - myDSC

Health and Research – Alzheimer's/Dementia

LuMind IDSC signs on to NTG statement re: Aduhelm

“It is unknown to what degree aducanumab (Aduhelm) may help people with Down syndrome, as…

Rigsby RigsbyOctober 27, 2021

Health and Research – Alzheimer's/Dementia

LuMind IDSC and Other National Groups Urge CMS to Include DS Community in Alzheimer’s Drugs Coverage

LuMind IDSC has joined the National Down Syndrome Society (NDSS) and The National Task Group…

Rigsby RigsbyOctober 27, 2021

Health and Research – Alzheimer's/Dementia

FDA Approves Biogen’s Aduhelm, the First New Drug for Alzheimer’s Disease Since 2003

Today marks an important milestone in Alzheimer’s disease research with the approval by the FDA…

Rigsby RigsbyOctober 27, 2021

Health and Research – Alzheimer's/Dementia

Progress in Alzheimer’s Disease Builds Renewed Interest in Research

In June of 2021, the FDA approved a new drug, Aduhelm, from the company Biogen…

Rigsby RigsbyOctober 27, 2021

Health and Research – Alzheimer's/Dementia

Biomarkers and Therapeutics for People with Down Syndrome and Alzheimer’s Disease

The NTG brought together a national panel of expert researchers and practitioners in the field…

Rigsby RigsbyOctober 20, 2021

Health and Research – Alzheimer's/Dementia

A New Perspective on The Aduhelm Controversy

In June, the FDA granted “accelerated approval” to Biogen’s Aduhelm drug. This is the first…

Rigsby RigsbyOctober 15, 2021

Health and Research – Alzheimer's/Dementia

Alzheimer’s Disease Video Journal Segment 8

The video below is segment 8a of our Alzheimer's Disease Video Journal, which consists of…

Rigsby RigsbyOctober 5, 2021

Health and Research – Alzheimer's/Dementia

Aging and Alzheimer’s Disease Webinar

The video below is a recording of a webinar presented by Brian Chicoine, MD and…

Capetivate capetivateSeptember 29, 2021

Health and Research – Alzheimer's/Dementia

Aging and Alzheimer’s Disease

This document contains the slides from a webinar on aging and Alzheimer's disease in presented…

Capetivate capetivateSeptember 29, 2021

Health and Research – Alzheimer's/Dementia

Alzheimer’s Disease Video Journal Segment 7

The video below is the seventh segment of our Alzheimer's Disease Video Journal, which consists…

Capetivate capetivateSeptember 13, 2021

alzheimer’s

LuMind IDSC signs on to NTG statement re: Aduhelm

LuMind IDSC and Other National Groups Urge CMS to Include DS Community in Alzheimer’s Drugs Coverage

FDA Approves Biogen’s Aduhelm, the First New Drug for Alzheimer’s Disease Since 2003

Progress in Alzheimer’s Disease Builds Renewed Interest in Research

Biomarkers and Therapeutics for People with Down Syndrome and Alzheimer’s Disease

A New Perspective on The Aduhelm Controversy

Alzheimer’s Disease Video Journal Segment 8

Aging and Alzheimer’s Disease Webinar

Aging and Alzheimer’s Disease

Alzheimer’s Disease Video Journal Segment 7

CONTACT LUMIND IDSC

QUICK LINKS

JOIN US